Open access
Jul 2026
Long-term adherence to glucose-lowering therapy and cardiovascular risk in type 2 diabetes: a nationwide cohort study
Long-term adherence to glucose-lowering medication was associated with lower cardiovascular rate and longer event-free survival time among individuals with newly diagnosed type 2 diabetes.
Lise B. Nielsen, A. Bartholdy, Tri-Long Nguyen et al.
· The Lancet Regional Health -... · 0 citations